Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Neoplasms, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06625515
What this trial is testing

First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers

Who this might be right for
Advanced Solid TumorsBreast Cancer RecurrentColorectal Cancer Metastatic+3 more
Accent Therapeutics 17
Early research (Phase 1)Study completedNCT02562378
What this trial is testing

T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
MedSIR 15
Not applicableStudy completedNCT03161392
What this trial is testing

Correlation of Solitary Dilated Duct at Mammography With Ultrasonography and Anatomopathological Findings

Who this might be right for
Mammary Duct Ectasia of Unspecified BreastMammographic FindingsFemale
Faculdade de Medicina do ABC 135
Not applicableLooking for participantsNCT03823144
What this trial is testing

Intravital Microscopy in Human Solid Tumors

Who this might be right for
Solid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm+20 more
Mayo Clinic 85
Not applicableStudy completedNCT00918892
What this trial is testing

Assessment of Candidate Protein Expression in Breast Cancer Specimens

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 460
Large-scale testing (Phase 3)Study completedNCT01702571
What this trial is testing

Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2,185
Early research (Phase 1)Looking for participantsNCT06533332
What this trial is testing

Trial of ERX-315 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Breast CancerMetastatic Ovarian Cancer+3 more
EtiraRx Australia Pty Ltd 36
Early research (Phase 1)Study completedNCT03096054
What this trial is testing

A Phase I Trial of LY3143921 Hydrate in Solid Tumours

Who this might be right for
Colorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more
Cancer Research UK 69
Early research (Phase 1)Study completedNCT01286987
What this trial is testing

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Who this might be right for
Advanced or Recurrent Solid TumorsBreast NeoplasmsOvarian Cancer, Epithelial+4 more
Pfizer 113
Testing effectiveness (Phase 2)Ended earlyNCT00558545
What this trial is testing

A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer

Who this might be right for
Human Mammary Carcinoma
Aegera Therapeutics 61
Not applicableUnknownNCT01850628
What this trial is testing

NSABP Biospecimen Discovery Project

Who this might be right for
Breast Cancer
NSABP Foundation Inc 50
Large-scale testing (Phase 3)Study completedNCT01935492
What this trial is testing

8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastMetastatic Breast Cancer
Borstkanker Onderzoek Groep 420
Not applicableLooking for participantsNCT03335644
What this trial is testing

The NutriNet-Santé Study

Who this might be right for
Diet, Food, and NutritionExerciseDiseases Category+7 more
University of Paris 13 170,000
Not applicableEnded earlyNCT00358098
What this trial is testing

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AHS Cancer Control Alberta 51
Not applicableStudy completedNCT04460898
What this trial is testing

RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.

Who this might be right for
Breast Cancer
Pfizer 195
Early research (Phase 1)Ended earlyNCT02964507
What this trial is testing

Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer

Who this might be right for
Neoplasms
GlaxoSmithKline 124
Large-scale testing (Phase 3)Study completedNCT01566721
What this trial is testing

A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Hoffmann-La Roche 2,577
Large-scale testing (Phase 3)Looking for participantsNCT04263298
What this trial is testing

Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Herui Yao 210
Early research (Phase 1)Ended earlyNCT03816839
What this trial is testing

Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)

Who this might be right for
Breast Cancer
Sanofi 10
Early research (Phase 1)Looking for participantsNCT05304962
What this trial is testing

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Regor Pharmaceuticals Inc. 64
Next Page